UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024483
Receipt number R000028162
Scientific Title Non randomized single-arm study of cervical partial resection and diathermy for CIN
Date of disclosure of the study information 2016/11/01
Last modified on 2021/06/27 11:11:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Non randomized single-arm study of cervical partial resection and diathermy for CIN

Acronym

diathermy for CIN

Scientific Title

Non randomized single-arm study of cervical partial resection and diathermy for CIN

Scientific Title:Acronym

diathermy for CIN

Region

Japan


Condition

Condition

CIN2/3

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

efficacy and safety of local treatment of uterine cervix

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

recurrence of the disease in 24 months

Key secondary outcomes

1.efficacy of HPV testing for reccurrence
2.monitoring adverse effects


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

operation, once

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >=

Gender

Female

Key inclusion criteria

1.patients obtained documents of fully informed consent
2.patients aged from 20 to 50.
3.diagnosed with CIN2/3
4.disease area is not occupied in whole cervix
5. PS 0 or 1
6.no past history of cone, vapolization or hysterectomy

Key exclusion criteria

1.impossible conservative observation due to severe complication
2.no active double cancer
3.psychic disorder
4.pregnant
5.inadequate condition judged by doctors

Target sample size

60


Research contact person

Name of lead principal investigator

1st name TAKUMA
Middle name
Last name FUJII

Organization

Fujita Health University

Division name

Department of Obstetrics and Gynecology

Zip code

470-1192

Address

Kutsukakecho,Toyoake, Aichi

TEL

0562-93-2111

Email

fujiit44@fujita-hu.ac.jp


Public contact

Name of contact person

1st name TAKUMA
Middle name
Last name FUJII

Organization

Fujita Health University

Division name

department of Obstetrics and Gynecology

Zip code

470-1192

Address

Kutsukakecho, Toyoake, Aichi

TEL

0562-93-9294

Homepage URL


Email

fujiit44@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University

Address

1-98,Dengakugakubo,kutsukakecho,Toyoake,Aichi,Japan

Tel

0562-93-2111

Email

fujiit44@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

藤田医科大学(愛知県)


Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 10 Month 13 Day

Date of IRB

2016 Year 10 Month 13 Day

Anticipated trial start date

2016 Year 11 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry

2021 Year 12 Month 31 Day

Date trial data considered complete

2021 Year 12 Month 31 Day

Date analysis concluded

2022 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 10 Month 19 Day

Last modified on

2021 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028162